Author
Listed:
- Michael B. Burns
(Biochemistry, University of Minnesota
Masonic Cancer Center, University of Minnesota
Institute for Molecular Virology, University of Minnesota
Center for Genome Engineering, University of Minnesota)
- Lela Lackey
(Biochemistry, University of Minnesota
Masonic Cancer Center, University of Minnesota
Institute for Molecular Virology, University of Minnesota
Center for Genome Engineering, University of Minnesota)
- Michael A. Carpenter
(Biochemistry, University of Minnesota
Masonic Cancer Center, University of Minnesota
Institute for Molecular Virology, University of Minnesota
Center for Genome Engineering, University of Minnesota)
- Anurag Rathore
(Biochemistry, University of Minnesota
Masonic Cancer Center, University of Minnesota
Institute for Molecular Virology, University of Minnesota
Center for Genome Engineering, University of Minnesota)
- Allison M. Land
(Biochemistry, University of Minnesota
Masonic Cancer Center, University of Minnesota
Institute for Molecular Virology, University of Minnesota
Center for Genome Engineering, University of Minnesota)
- Brandon Leonard
(Masonic Cancer Center, University of Minnesota
Institute for Molecular Virology, University of Minnesota
Center for Genome Engineering, University of Minnesota
Microbiology, Cancer Biology and Immunology Graduate Program, University of Minnesota)
- Eric W. Refsland
(Biochemistry, University of Minnesota
Masonic Cancer Center, University of Minnesota
Institute for Molecular Virology, University of Minnesota
Center for Genome Engineering, University of Minnesota)
- Delshanee Kotandeniya
(Masonic Cancer Center, University of Minnesota
University of Minnesota)
- Natalia Tretyakova
(Masonic Cancer Center, University of Minnesota
University of Minnesota)
- Jason B. Nikas
(Masonic Cancer Center, University of Minnesota)
- Douglas Yee
(Masonic Cancer Center, University of Minnesota)
- Nuri A. Temiz
(In Silico Research Centers of Excellence, Advanced Biomedical Computing Center, Information Systems Program, SAIC-Frederick Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA)
- Duncan E. Donohue
(In Silico Research Centers of Excellence, Advanced Biomedical Computing Center, Information Systems Program, SAIC-Frederick Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA)
- Rebecca M. McDougle
(Biochemistry, University of Minnesota
Masonic Cancer Center, University of Minnesota
Institute for Molecular Virology, University of Minnesota
Center for Genome Engineering, University of Minnesota)
- William L. Brown
(Biochemistry, University of Minnesota
Masonic Cancer Center, University of Minnesota
Institute for Molecular Virology, University of Minnesota
Center for Genome Engineering, University of Minnesota)
- Emily K. Law
(Biochemistry, University of Minnesota
Masonic Cancer Center, University of Minnesota
Institute for Molecular Virology, University of Minnesota
Center for Genome Engineering, University of Minnesota)
- Reuben S. Harris
(Biochemistry, University of Minnesota
Masonic Cancer Center, University of Minnesota
Institute for Molecular Virology, University of Minnesota
Center for Genome Engineering, University of Minnesota)
Abstract
The DNA cytosine deaminase APOBEC3B is shown to be overexpressed and highly active in most breast cancers; deamination by APOBEC3B could serve as an endogenous, continual source of DNA damage leading to mutations, including C-to-T transitions and other aberrations seen in many breast tumours.
Suggested Citation
Michael B. Burns & Lela Lackey & Michael A. Carpenter & Anurag Rathore & Allison M. Land & Brandon Leonard & Eric W. Refsland & Delshanee Kotandeniya & Natalia Tretyakova & Jason B. Nikas & Douglas Ye, 2013.
"APOBEC3B is an enzymatic source of mutation in breast cancer,"
Nature, Nature, vol. 494(7437), pages 366-370, February.
Handle:
RePEc:nat:nature:v:494:y:2013:i:7437:d:10.1038_nature11881
DOI: 10.1038/nature11881
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Atanu Maiti & Adam K. Hedger & Wazo Myint & Vanivilasini Balachandran & Jonathan K. Watts & Celia A. Schiffer & Hiroshi Matsuo, 2022.
"Structure of the catalytically active APOBEC3G bound to a DNA oligonucleotide inhibitor reveals tetrahedral geometry of the transition state,"
Nature Communications, Nature, vol. 13(1), pages 1-10, December.
- Stefan Harjes & Harikrishnan M. Kurup & Amanda E. Rieffer & Maitsetseg Bayarjargal & Jana Filitcheva & Yongdong Su & Tracy K. Hale & Vyacheslav V. Filichev & Elena Harjes & Reuben S. Harris & Geoffrey, 2023.
"Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A,"
Nature Communications, Nature, vol. 14(1), pages 1-13, December.
- Eriko Tokunaga & Nami Yamashita & Kimihiro Tanaka & Yuka Inoue & Sayuri Akiyoshi & Hiroshi Saeki & Eiji Oki & Hiroyuki Kitao & Yoshihiko Maehara, 2016.
"Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women,"
PLOS ONE, Public Library of Science, vol. 11(12), pages 1-11, December.
- Yasha Butt & Ramin Sakhtemani & Rukshana Mohamad-Ramshan & Michael S. Lawrence & Ashok S. Bhagwat, 2024.
"Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations,"
Nature Communications, Nature, vol. 15(1), pages 1-13, December.
- Ambrocio Sanchez & Pedro Ortega & Ramin Sakhtemani & Lavanya Manjunath & Sunwoo Oh & Elodie Bournique & Alexandrea Becker & Kyumin Kim & Cameron Durfee & Nuri Alpay Temiz & Xiaojiang S. Chen & Reuben , 2024.
"Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes,"
Nature Communications, Nature, vol. 15(1), pages 1-16, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:494:y:2013:i:7437:d:10.1038_nature11881. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.